Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Sales | 117 | 1 | 2 | 16 | 6 |
Cost of Goods | 0 | 0 | 139 | 30 | 73 |
Gross Profit | 117 | 1 | -137 | -14 | -67 |
Operating Expenses | 1,094 | 3,446 | 1,964 | 2,171 | 2,200 |
Operating Income | -977 | -3,444 | -1,962 | -2,155 | -2,194 |
Interest Expense | 260 | 685 | 1,103 | 1,219 | 115 |
Other Income | -147 | 148 | -90 | 4 | 75 |
Pre-tax Income | -1,384 | -3,981 | -3,154 | -3,369 | -2,234 |
Income Tax | -111 | N/A | 175 | -1 | 82 |
Net Income Continuous | -1,273 | -3,981 | -3,330 | -3,368 | -2,315 |
Minority Interests | -260 | -48 | -219 | -51 | -52 |
Net Income | $-1,013 | $-3,933 | $-3,111 | $-3,318 | $-2,264 |
EPS Basic Total Ops | -0.09 | -0.40 | -0.38 | -0.82 | -0.68 |
EPS Basic Continuous Ops | -0.11 | -0.41 | -0.41 | -0.83 | -0.70 |
EPS Diluted Total Ops | -0.09 | -0.40 | -0.38 | -0.82 | -0.68 |
EPS Diluted Continuous Ops | -0.11 | -0.41 | -0.41 | -0.83 | -0.70 |
EPS Diluted Before Non-Recurring Items | N/A | -0.40 | -0.35 | -0.82 | -0.68 |
EBITDA(a) | $-963 | $-3,443 | $-1,954 | $-2,147 | $-2,187 |